This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB01910/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB01910/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01910/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB01910/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB01910/identifier/pubchem-substance/

Statements

Subject Item
n2:DB01910
rdf:type
n3:Drug
n3:description
Adenosyl-ornithine is a solid. This compound belongs to the purine nucleosides and analogues. These are compounds comprising a purine base attached to a sugar. The proteins that adenosyl-ornithine target include RdmB, modification methylase TaqI, rRNA (adenine-N6-)-methyltransferase, and modification methylase RsrI.
n3:group
experimental
owl:sameAs
n6:DB01910 n13:DB01910
dcterms:title
Adenosyl-Ornithine
adms:identifier
n8:46508037 n9:SFG n10:46936257 n11:3280577 n12:DB01910
n3:IUPAC-Name
n4:271B5254-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B525A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5259-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5256-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5257-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5258-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5252-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5250-363D-11E5-9242-09173F13E4C5 n4:271B5253-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5251-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5260-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5261-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B525B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B525C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B525E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B525D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B525F-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
58944-73-3
n3:category
n3:Bioavailability
n4:271B5266-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5268-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5269-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5265-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5264-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5267-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5255-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5262-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5263-363D-11E5-9242-09173F13E4C5